Targeted Myocardial Microinjections of a Biocomposite Material Reduces Infarct Expansion in Pigs

Targeted myocardial microinjection of the biocomposite attenuated the post-MI decrease in LV wall thickness and infarct expansion. Thus, intraoperative microinjections of biocompatible material may provide a novel approach for interrupting post-MI LV remodeling.